Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Conference Coverage
New BACE1 study launches in the shadow of verubecestat’s demise
Publish date:
November 4, 2017
AT CTAD
msullivan@frontlinemedcom.com
On Twitter
@Alz_Gal
Pages
« first
1
2
Recommended Reading
Cognitive decline not seen with lower BP treatment targets
MDedge Family Medicine
Fueling the Alzheimer’s brain with fat
MDedge Family Medicine
Study linked H2 receptor antagonists, but not PPIs, to dementia
MDedge Family Medicine
Higher BP targets suggested for elderly, cognitively impaired
MDedge Family Medicine
Personality changes may not occur before Alzheimer’s onset
MDedge Family Medicine
APOE affects tau pathology independent of amyloid-beta
MDedge Family Medicine
VIDEO: Alzheimer’s blood test expected soon
MDedge Family Medicine
AF patients without oral anticoagulation face higher dementia risk
MDedge Family Medicine
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Family Medicine
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Family Medicine
Neurology
Geriatrics
All Specialties
